T here are~78 million people infected with hepatitis B virus (HBV) in China; among them, 28 million individuals with chronic hepatitis B (CHB) require antiviral treatment. Previous studies have shown that CHB patients who are not receiving treatment have a significantly lower quality of life than those who have received efficient treatment, and also have a significantly increased risk of cirrhosis and liver cancer progression. 1 Efficient antiviral treatment is associated with the restoration of the immune capabilities of the host and the quantity and function of effector T-cells and regulatory T-cells (Tregs). 2 In addition, Tregs could be used as a potential immune marker to evaluate the progression and prognosis of chronic HBV infection.
CD4 + CD25 + Tregs constitute 5-10% of peripheral CD4 + T-cells in the blood, and they play a key role in maintaining immunologic self-tolerance by actively suppressing self-reactive lymphocytes. 3 Tregs are classified into two categories: thymus-derived Tregs (previously known as naturally occurring Tregs) and peripheral Tregs (previously labeled adaptive Tregs). 4 Tregs are a population of CD4 + T-cells with high expression levels of CD25 and nuclear transcription factor FoxP3, which was previously considered a specific surface marker on Treg. However, Rodriguez et al. discovered that FoxP3 was not only expressed on CD25 + T-cells, but also on an activated T-cell population. Thus, not all FoxP3 + cells are regulatory cells. 5 A recent study has shown that there is a positive relationship between the expression of FoxP3 and low expression levels of CD127 in CD4 + CD25 + purified cells. A three-labeling (CD4 + , CD25 + , CD127low/ − ) method can help differentiate Tregs from activated CD4 + T-cells and can increase the number of Tregs detected. In addition, this method does not affect the activity of the cells. At present, this method is an ideal way to index Treg cells. 6 Studies have shown that Tregs have a unique immune response and negative immune regulation function, which play an important role in inducing autoimmune tolerance and maintaining immune balance. Their mechanism of action is mainly through direct contact between cells, secretion of inhibitory cytokines, such as IL-10, IL-35 and TGF-beta, and inhibition of DC maturation, thereby suppressing the immune inflammatory reaction. 7 HBV infection shows no direct cytopathology in infected hepatocytes; both hepatic cell damage and viral control are immune mediated. 8 The balance of effector and regulatory cells generally determines the outcome of hepatic inflammation: resolution, fulminant hepatitis or chronic active hepatitis. Thus, maintaining and adjusting this balance is crucial for the immunological manipulation of liver disease. 9 One of the options to restore the balance is to modify Tregs in patients with liver disease. Recently, there have been many reports of the mechanisms involved in maintaining Treg stability. Overacre et al. 10 found that a high proportion of intratumoral Neuropilin-1 (Nrp1) − / − Tregs produces interferon-γ (IFN-γ), which drives the fragility of surrounding wild-type Tregs, yet at the same time has no autoimmune adverse effects. Moreover, Wu et al. 11 suggested that liver kinase b1 (Lkb1) maintains Treg cell lineage identity by stabilizing FoxP3 expression and enforcing suppressor function (Figure 1) . Therefore, either of these molecules could be an important target to alter Treg identity and, thus, could be used to treat infectious disease and carcinoma.
By contrast, the composition and function of a specific T-cell population can be determined by the TCR CDR3 profile. 12 The TCR consists of a heterodimer of two chains (αβ or γδ), both of which are products of V(D)J recombination. The most variable region in the TCR is a complementarity-determining region 3 (CDR3), which has a critical role in antigen recognition. The current prevailing strategy for characterizing CDR3 sequences is TCR profiling by immunoscope technology 13 or high-throughput sequencing. 14 In issue 5, volume 13 (2016) of Cellular and Molecular Immunology,Yang et al. 15 described a novel TCRBV repertoire analysis technique (gene melting spectral pattern, GMSP) that could quickly detect the clonal property of TCRBV from peripheral blood samples from patients with CHB. The authors found that dynamic frequency and skewed TCRBV patterns of peripheral Tregs could contribute to predicting HBeAg seroconversion in CHB patients undergoing Tenofovir (TDF) treatment and that the conserved TCRBV (CDR3) motif could be targeted to develop personalized immunotherapy for CHB.
Recently, Zhang and other groups analyzed the transcriptome and TCR sequence of T lymphocytes in the microenvironment of hepatocellular carcinoma at the single-cell level and finished analyzing single-cell sequencing data for 45000 T-cells. A class of FoxP3+ inhibitory T-cells was found in the exhaustive CD8 T lymphocyte subsets, which suggested that this T-cell subset has the potential to further develop into inhibitory T-cells. 16 This evidence further proves that Tregs could be an important target for precision treatment of patients with chronic HBV infection.
In summary, the ability to modify the function of Tregs is an important means for the personalized treatment of infectious diseases, tumors, and autoimmune diseases. In addition, Nrp1, Lkb1 and antigen-specific TCRs would be crucial targets for the modification of Tregs. 
